Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Journal of Medical Case Reports
|
December 1, 2009
Cerebral involvement in a patient with Goodpasture's disease due to shortened induction therapy: a case report
Christoph Preul, Jens Gerth, Sebastian Lang, et al.
Kidney & Blood Pressure Research
|
November 8, 2011
Screening and differential diagnosis of renal light chain-associated diseases
Jens Gerth, Anja Sachse, Martin Busch, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
July 8, 2008
[Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?]
Martin Busch, Jens Gerth, Undine Ott, et al.
Kidney International
|
June 18, 2004
Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein
Martin Busch, Sybille Franke, Andreas Müller, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 26, 2006
The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension
Martin Busch, Sybille Franke, Gunter Wolf, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
October 10, 2002
[Pregnancy-associated thrombotic microangiopathy--a diagnostic and therapeutic challenge]
Jens Gerth, Martin Busch, Undine Ott, et al.
Nephron. Clinical Practice
|
October 10, 2009
Vitamin B6 metabolism in chronic kidney disease--relation to transsulfuration, advanced glycation and cardiovascular disease
Martin Busch, Andrea Göbert, Sybille Franke, et al.
Transplantation
|
September 24, 2005
Polyomavirus DNA and RNA detection in renal allograft biopsies: results from a European multicenter study
Holger Schmid, Hans Nitschko, Jens Gerth, et al.
The Journal of Clinical Investigation
|
May 24, 2016
Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy
Nicola M Tomas, Elion Hoxha, Anna T Reinicke, et al.
Blood Advances
|
July 8, 2020
Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura
Linus A Völker, Jessica Kaufeld, Wolfgang Miesbach, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Journal of Medical Case Reports
|
December 1, 2009
Cerebral involvement in a patient with Goodpasture's disease due to shortened induction therapy: a case report
Christoph Preul, Jens Gerth, Sebastian Lang, et al.
Kidney & Blood Pressure Research
|
November 8, 2011
Screening and differential diagnosis of renal light chain-associated diseases
Jens Gerth, Anja Sachse, Martin Busch, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
July 8, 2008
[Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?]
Martin Busch, Jens Gerth, Undine Ott, et al.
Kidney International
|
June 18, 2004
Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein
Martin Busch, Sybille Franke, Andreas Müller, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 26, 2006
The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension
Martin Busch, Sybille Franke, Gunter Wolf, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
October 10, 2002
[Pregnancy-associated thrombotic microangiopathy--a diagnostic and therapeutic challenge]
Jens Gerth, Martin Busch, Undine Ott, et al.
Nephron. Clinical Practice
|
October 10, 2009
Vitamin B6 metabolism in chronic kidney disease--relation to transsulfuration, advanced glycation and cardiovascular disease
Martin Busch, Andrea Göbert, Sybille Franke, et al.
Transplantation
|
September 24, 2005
Polyomavirus DNA and RNA detection in renal allograft biopsies: results from a European multicenter study
Holger Schmid, Hans Nitschko, Jens Gerth, et al.
The Journal of Clinical Investigation
|
May 24, 2016
Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy
Nicola M Tomas, Elion Hoxha, Anna T Reinicke, et al.
Blood Advances
|
July 8, 2020
Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura
Linus A Völker, Jessica Kaufeld, Wolfgang Miesbach, et al.
Page
of 3